Diabetes Mellitus Alters the Effect of Peptide and Protein Ligands on Membrane Fluidity of Blood Platelets

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Thrombosis and Haemostasis

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1055/S-0038-1650235PMID 8713794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered platelet functions in non-insulin-dependent diabetes mellitus (NIDDM).

  1994cited by this paper
• Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link.

  1994cited by this paper
• Tissue-type plasminogen activator induces alterations in structure and conformation of membrane proteins upon its interaction with human platelets.

  1993cited by this paper
• Microenvironment changes in human blood platelet membranes associated with binding of tissue-type plasminogen activator.

  1993cited by this paper
• Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects

  1993cited by this paper
• Lipid fluidity modulates platelet aggregation and agglutination in vitro.

  1993cited by this paper
• Altered Structural and Dynamic Properties of Blood Cell Membranes in Diabetes Mellitus

  1993cited by this paper
• Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.

  1992cited by this paper
• Platelet Abnormalities in Diabetes Mellitus

  1992cited by this paper
• Membrane Fluidity Is Related to the Extent of Glycation of Proteins, but not to Alterations in the Cholesterol to Phospholipid Molar Ratio in Isolated Platelet Membranes from Diabetic and Control Subjects

  1992cited by this paper
• Changes in Blood Coagulation, Platelet Function, and Plasminogen-Plasmin System in Diabetes

  1992cited by this paper
• Role of fibrinogen alpha and gamma chain sites in platelet aggregation.

  1992cited by this paper
• Decreased Platelet Membrane Fluidity Due to Glycation or Acetylation of Membrane Proteins

  1992cited by this paper
• Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients.

  1992cited by this paper
• The Fibrinolytic System in Diabetes Mellitus

  1991cited by this paper
• The hypersensitivity to thrombin of platelets from diabetic rats is not due to increased thrombin binding.

  1991cited by this paper
• May the alterations in lipid fluidity-mediated platelet hypersensitivity contribute to accelerated aging of platelets in diabetes mellitus?

  1991cited by this paper
• Nonenzymatic Glycation of Platelet Proteins in Diabetic Patients

  1991cited by this paper
• Vitamin E and platelet eicosanoids in diabetes mellitus.

  1990cited by this paper
• Reduced Membrane Fluidity in Platelets From Diabetic Patients

  1990cited by this paper
• Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension.

  1989cited by this paper
• NONENZYMATIC GLYCATI0N OF HUMAN BLOOD PLATELET PROTEINS

  1989cited by this paper
• Fibrinogen interaction with platelets of diabetic subjects.

  1987cited by this paper
• Nonenzymatic glycation of human platelet membrane proteins in vitro and in vivo.

  1986cited by this paper
• Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.

  1986cited by this paper
• Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.

  1986cited by this paper
• THE SPIN‐LABEL APPROACH TO LABELING MEMBRANE PROTEIN SULFHYDRYL GROUPS *

  1983cited by this paper
• Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity

  1982cited by this paper
• Interfacial free energies and the control of the positioning and aggregation of membrane protein.

  1982cited by this paper
• Vitamin E changes the membrane fluidity of human platelets.

  1981cited by this paper
• Lateral and transversal diffusion and phase transitions in erythrocyte membranes. An excimer fluorescence study.

  1980cited by this paper
• The effect of membrane cholesterol depletion upon erythrocyte membrane-bound enzymes.

  1979cited by this paper
• Subcellular distribution of the different platelet proteins phosphorylated on exposure of intact platelets to ionophore A23187 or to prostaglandin E1. Possible role of a membrane phosphopolypeptide in the regulation of calcium-ion transport.

  1979cited by this paper
• Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells.

  1978cited by this paper
• Microviscosity parameters and protein mobility in biological membranes.

  1976cited by this paper
• Increased platelet aggregation in early diabetus mellitus.

  1975cited by this paper
• Amino acid sequence studies on artiodactyl fibrinopeptides. I. Dromedary camel, mule deer, and cape buffalo.

  1967cited by this paper
• PLATELET SEQUESTRATION IN MAN. I. METHODS.

  1964cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Lipophilic index of serum phospholipids in patients with type 2 diabetes and atherosclerotic cardiovascular disease: links with metabolic control, vascular inflammation and platelet activation

  2024cites this paper
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• Measurement of Mean Platelet Volume and Platelet Distribution Width among Uncontrolled Type 2 Diabetic Sudanese Patients

  2019cites this paper
• The impact of hyperglycemia and hyperlipidemia on plasma P-selectin and platelet markers after ischemic stroke

  2017cites this paper
• How do the full-generation poly(amido)amine (PAMAM) dendrimers activate blood platelets? Platelet membrane zeta potential and other membrane-associated phenomena.

  2016cites this paper
• Platelet activation patterns are different in mouse models of diabetes and chronic inhibition of nitric oxide synthesis.

  2014cites this paper
• ANTIGLYCATION AND ANTIOXIDATION PROPERTIES OF BERBERIS LYCEUM AND TERMINALIA CHEBULA: POSSIBLE ROLE IN CURING DIABETES AND SLOWING AGING

  2014cites this paper
• Comparison of Platelet CD Markers between Normal Individuals and Untreated Patients with Type 2 Diabetes Mellitus

  2013cites this paper
• Platelet Cd Markers By Flow Cytometry In Normal Individuals And In Patients With Untreated Type 2 Diabetes Mellitus

  2013cites this paper
• Chapter 35 – Diabetes Mellitus

  2013cites this paper
• Antiglycation and antioxidation properties of Juglans regia and Calendula officinalis: possible role in reducing diabetic complications and slowing down ageing.

  2012cites this paper
• PLATELETS STRUCTURAL, FUNCTIONAL AND METABOLIC ALTERATIONS IN DIABETES MELLITUS

  2012cites this paper
• Platelet adhesion in atherogenesis

  2010cites this paper
• Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux

  2009cites this paper
• Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications

  2007cites this paper
• Wpływ cukrzycy na różne drogi metabolizmu reszty acetylowej i funkcję płytek krwi

  2007cites this paper
• Cyclooxygenase expression in human diabetes

  2006cites this paper
• Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes.

  2006cites this paper
• Regulation of vascular genes by glucose.

  2005cites this paper
• Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus.

  2005cites this paper
• Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus.

  2005influential citation
• Platelet activation in type 2 diabetes mellitus

  2004cites this paper
• Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes.

  2004cites this paper
• Screening System for the Maillard Reaction Inhibitor from Natural Product Extracts

  2002cites this paper
• Coagulation and Fibrinolysis in Diabetes

  2002cites this paper
• Infrared spectroscopic study of diabetic platelets

  2002cites this paper
• Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine.

  2000cites this paper
• Oxidative response and membrane modification of diabetic platelets challenged with PAF.

  2000cites this paper
• Improved glycemic control and platelet function abnormalities in diabetic patients with microvascular disease.

  2000cites this paper
• The role of platelets in diabetes-related vascular complications.

  2000cites this paper
• Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity?

  1999cites this paper
• Apoptosis and oxidative status in peripheral blood mononuclear cells of diabetic patients

  1999cites this paper
• Does reduced membrane lipid fluidity underlie the altered thrombin-induced expression of integrin α(IIb)β(3) and PADGEM-140 in membranes of platelets from diabetic juveniles?

  1996cites this paper